Rugecitide

鲁戈西肽

Report date: 2025/11/11 17:42:53

Base Information

Drug NameRugecitide
Drug Alias NameLY-3461767
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionNeuregulin-4 agonists
TargetsNeuregulin-4
Therapy Area/IndicationsHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSingaporeJapan
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesEli Lilly And Company
Inactive CompaniesN/A
Active IndicationsHeart Failure
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A